Aurora Sterilisation

Press Release For immediate release Date: May 19, 2026 Aurora Sterilisation secures EUR 10.8 million in funding under the IPCEI Tech4Cure programme to accelerate the ecological transition of single-use medical device sterilisation Aurora Sterilisation ("Aurora"), an innovative company in the field of medical sterilisation, announces the securing of €10.8 million in grants and repayable advances. This funding, obtained under the IPCEI Tech4Cure programme and operated by Bpifrance, will enable Aurora to support medical device manufacturers in the ecological transition of their product sterilisation processes. - Aurora's cutting-edge technology addresses critical challenges in the medical sector by: - Protecting patients from infections related to single-use medical devices; Facilitating the introduction of new medical devices through an adapted sterilisation process; - Using a sterilising agent that is safe for human health and the environment, while remaining energy-efficient. Jan Laarman, Chief Executive Officer of Aurora, states: "We are extremely proud and grateful to have secured this funding. It reflects the confidence of European and French public authorities in our technology and its ability to meet the current challenges facing the medical device industry. At Aurora, we firmly believe that the sterilisation of tomorrow can no longer be separated from the ecological imperative. Our process not only guarantees maximum patient safety, but also supports manufacturers in their transition towards more sustainable solutions, while significantly reducing the environmental footprint of sterilisation. With this new support, we will be able to accelerate the deployment of our technology among European industrial players, foster the emergence of more innovative and environmentally responsible medical devices, and make a tangible contribution to Europe's health sovereignty. This is a decisive step for Aurora, but above all for the entire healthcare value chain." Press contact: Aurora Sterilisation – 177, boulevard de l'Yser - 76000 Rouen Jan Laarman Email: jan.laarman@aurora-sterilisation.com Website: https://lnkd.in/euGkTHHc About Aurora Sterilisation Aurora Sterilisation develops an innovative sterilisation technology for medical devices, aimed at protecting patients, supporting medical innovation and preserving the environment through an energy-efficient process that poses no risk to human health. This technology uses natural plasmas generated from pure air gas. Aurora is based in Rouen and Reims. End of press release

The US patients need US investors and US partners. Thank you Jerome Revole for your support at the JP Morgan Week 2026.

✈️ A look back at Hong Kong 🇭🇰 Last week, our team flew to Hong Kong to take part to the WFHSS congress. 🔹 On the agenda: • Presentation of our solution • Meetings and discussions with hospital teams • Attendance at several specialised conferences Many thanks to the professionals we met for the quality of the discussions we had about sterilisation practices Hervé NEYJulien MOLINA Lionel Pineau At Aurora Sterilisation, we place listening, knowledge sharing, and collaboration at the heart of our commitments to support the evolution of practices in the sector. We are looking forward to the next WFHSS Congress- Official Page in Belgrade 🇷🇸 2026.

✈️ A look back at Hong Kong 🇭🇰 Last week, our team flew to Hong Kong to take part to the WFHSS congress. 🔹 On the agenda: • Presentation of our solution • Meetings and discussions with hospital teams • Attendance at several specialised conferences Many thanks to the professionals we met for the quality of the discussions we had about sterilisation practices Hervé NEYJulien MOLINA Lionel Pineau At Aurora Sterilisation, we place listening, knowledge sharing, and collaboration at the heart of our commitments to support the evolution of practices in the sector. We are looking forward to the next WFHSS Congress- Official Page in Belgrade 🇷🇸 2026.

At Aurora, our engineers installed our special Christmas tree 🎄 Alaric L. Gael DURBECQ Julien Arné Mickael Chevallot Justin Guérinot Florian Le Bras

✈️ Our team is flying to Hong Kong ! 🇭🇰 This is a great opportunity for us to share and discuss our latest innovation.  Visit us at booth G06. Jan Laarman, Christophe Boyer and Sarah Sadouni, PhD will be happy to answer all your questions.   🗓 December 3-6, 2025   📍 WFHSS - World Sterilization Congress, Asian World, Hong Kong, China #innovationInSterilization #innovation #medicaldevice #WFHSS2025 #HealthcareTech 

Big milestone for Aurora Sterilisation! We are thrilled to announce the successful closing of a €3.8 million bond loan – a decisive step toward revolutionizing the sterilization of medical devices. This financing, backed by the EIC Fund (EIC - European Innovation Council) and our loyal historical shareholders GO Capital (Alexandre Boulay) and Normandie Participations (Arthur Duwiquet), builds on the EIC Accelerator grant and equity commitment we received in 2023 (up to €10M total support from the EIC). With these new resources, we are accelerating the final development and industrial scale-up of our breakthrough natural air-gas plasma technology, with commercial launch planned for 2026. Why this matters:  ✅ Protects patients from infections linked to complex reusable devices that are currently impossible to sterilize properly ✅ Unlocks innovation by enabling the market entry of tomorrow’s medical devices ✅ Delivers a sterilizing agent that is safe for human health and the environment while being highly energy-efficient This funding round marks a decisive milestone. With the support of the EIC Fund and our long-standing investors, we can finalise the development of our technology and deliver an innovative solution that will enhance patient safety while respecting the environment. Svetoslava Georgieva, Chair of the EIC Fund Board, said: “We are happy to see Aurora successfully close this funding round, which demonstrates strong investor confidence in their vision and capacity to scale. They are delivering exactly the kind of breakthrough innovation Europe needs — combining scientific excellence with tangible societal impact”. A huge thank you to our investors, partners, and the entire Aurora team for their trust and relentless commitment. Together, we are modernizing sterilization practices and building a safer, more sustainable future for healthcare. #MedTech #HealthTech #DeepTech #PatientSafety #Sustainability #EICAccelerator #Innovation #StartUp https://lnkd.in/euGkTHHc

Ethylene oxide is a costly sterilant for MD manufacturers : BD paid $20m as compensation for a EtO-induced cancer on a driver from its sterilisation facility

📢 FineHeart, CorWave et Aurora Sterilisation lauréats du Projet important d’intérêt européen commun (PIIEC) en santé « Tech4Cure », dédié aux dispositifs médicaux innovants ! 🇪🇺 Initié en 2022, le PIIEC santé vise à faire émerger des champions européens pour renforcer les capacités de production européennes et stimuler la formation de partenariats européens ambitieux autour de projets d’innovation. Fin juillet, la Commission européenne a dévoilé les porteurs de projets « Tech4Cure », dont 3 sont membres de MedTech in France 🇫🇷 : ➡️ FineHeart, avec le projet « SmartDMIA » pour concevoir une nouvelle génération d’implants intelligents, capables de transférer de l’énergie et des données sans fil, directement à travers la peau ➡️ CorWave, qui ambitionne de développer un dispositif d'assistance ventriculaire gauche de nouvelle génération, plus compact et économe en énergie, et un système de transfert d'énergie transcutané ➡️ Aurora, en tant qu'entreprise partenaire associée, pour le développement d'un procédé innovant utilisant uniquement les gaz de l’air pour une stérilisation rapide des dispositifs médicaux   Une très belle reconnaissance du savoir-faire d’excellence français. Fiers de nos membres ! arnaud Mascarell Louis de Lillers Jan Laarman 💪 Pour en savoir plus : https://lnkd.in/eG5FSYg8